Biomarkers of Breast Cancer

Introduction: Breast cancer treatment has experienced several changes in the past decades due to the discovery of specific prognostic and predictive biomarkers that enable the application of more individualized therapies to different molecular subgroups. This study determined biomarkers of breast cancer. Material and methods: This was a hospital based cross sectional observational study conducted for one year from 1st June 2019 to 31st May 2020 in the Department of Pathology, Indira Gandhi Medical College, Shimla. Results: 31 (60.8%) cases were ER positive and 20 (39.2%) were ER negative as per Allred Scoring. In our study, 28 (54.9%) cases were PR positive and 23 (45.1%) were PR negative as per Allred Scoring. Conclusion: Assessment of ER and PR is important for prognosis.